Follow
Bhaven Sampat
Title
Cited by
Cited by
Year
The growth of patenting and licensing by US universities: an assessment of the effects of the Bayh–Dole act of 1980
DC Mowery, RR Nelson, BN Sampat, AA Ziedonis
Research policy 30 (1), 99-119, 2001
21352001
Ivory tower and industrial innovation: University-industry technology transfer before and after the Bayh-Dole Act
DC Mowery, RR Nelson, BN Sampat, AA Ziedonis
Stanford University Press, 2015
14652015
Universities in national innovation systems
DC Mowery, BN Sampat
13672006
Making sense of institutions as a factor shaping economic performance
RR Nelson, BN Sampat
Journal of economic behavior & organization 44 (1), 31-54, 2001
13412001
The Bayh-Dole Act of 1980 and university–industry technology transfer: a model for other OECD governments?
DC Mowery, BN Sampat
The Journal of Technology Transfer 30, 115-127, 2004
9702004
How do university inventions get into practice?
J Colyvas, M Crow, A Gelijns, R Mazzoleni, RR Nelson, N Rosenberg, ...
Management science 48 (1), 61-72, 2002
9262002
Patenting and US academic research in the 20th century: The world before and after Bayh-Dole
BN Sampat
Research Policy 35 (6), 772-789, 2006
4912006
Applicant and examiner citations in US patents: An overview and analysis
J Alcácer, M Gittelman, B Sampat
Research Policy 38 (2), 415-427, 2009
4612009
Changes in university patent quality after the Bayh–Dole act: a re-examination
BN Sampat, DC Mowery, AA Ziedonis
International Journal of Industrial Organization 21 (9), 1371-1390, 2003
4272003
Learning to patent: Institutional experience, learning, and the characteristics of US university patents after the Bayh-Dole Act, 1981-1992
DC Mowery, BN Sampat, AA Ziedonis
Management Science 48 (1), 73-89, 2002
3742002
How do patents affect follow-on innovation? Evidence from the human genome
B Sampat, HL Williams
American Economic Review 109 (1), 203-236, 2019
3732019
Public R&D investments and private-sector patenting: evidence from NIH funding rules
P Azoulay, JS Graff Zivin, D Li, BN Sampat
The Review of economic studies 86 (1), 117-152, 2019
3612019
Evergreening, patent challenges, and effective market life in pharmaceuticals
CS Hemphill, BN Sampat
Journal of health economics 31 (2), 327-339, 2012
3072012
Examiner characteristics and patent office outcomes
MA Lemley, B Sampat
Review of economics and statistics 94 (3), 817-827, 2012
2922012
University patents and patent policy debates in the USA, 1925–1980
DC Mowery, BN Sampat
Industrial and corporate change 10 (3), 781-814, 2001
2852001
Is the patent office a rubber stamp
MA Lemley, B Sampat
Emory LJ 58, 181, 2008
2652008
Patenting and licensing university inventions: lessons from the history of the research corporation
DC Mowery, BN Sampat
Industrial and Corporate Change 10 (2), 317-355, 2001
2442001
Do applicant patent citations matter?
CA Cotropia, MA Lemley, B Sampat
Research Policy 42 (4), 844-854, 2013
2102013
When do generics challenge drug patents?
CS Hemphill, BN Sampat
Journal of Empirical Legal Studies 8 (4), 613-649, 2011
1932011
What are the respective roles of the public and private sectors in pharmaceutical innovation?
BN Sampat, FR Lichtenberg
Health affairs 30 (2), 332-339, 2011
1912011
The system can't perform the operation now. Try again later.
Articles 1–20